Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive Systemic Sclerosis”

584 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 584 results

Not applicableLooking for participantsNCT04265144
What this trial is testing

Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre

Who this might be right for
SclerodermaSystemic Sclerosis
University Hospital, Bordeaux 500
Early research (Phase 1)Not Yet RecruitingNCT06489652
What this trial is testing

89Zr-Oxine-RY_SW01 Cell Injection for the Treatment of Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Jiangsu Renocell Biotech Company 8
Not applicableLooking for participantsNCT06503224
What this trial is testing

An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
The First Affiliated Hospital of University of Science and Technology of China 18
Not applicableStudy completedNCT00213460
What this trial is testing

Small Bowel Motor Impairment in Scleroderma: Results of a Prospective 5-year Manometric Follow-up

Who this might be right for
Systemic Sclerosis
University Hospital, Rouen
Testing effectiveness (Phase 2)Study completedNCT04388176
What this trial is testing

Cold Challenge With C21 in RP

Who this might be right for
Raynaud PhenomenonSystemic Sclerosis
Vicore Pharma AB 20
Not applicableEnrolling By InvitationNCT06658470
What this trial is testing

Hand Disability In Systemic Sclerosis - Digital Ulcers

Who this might be right for
Systemic Sclerosis (SSc)Digital Ulcer
Pamukkale University 72
Post-approval studies (Phase 4)Study completedNCT03692299
What this trial is testing

Effectiveness of Saccharomyces Boulardii for Gastrointestinal Bacterial-overgrowth in Systemic Sclerosis

Who this might be right for
Systemic SclerosisSmall Intestinal Bacterial Overgrowth
Coordinación de Investigación en Salud, Mexico 39
Not applicableNot Yet RecruitingNCT06769399
What this trial is testing

Relationship Between Pelvic Floor Dysfunctions and Sexual Dysfunction in Female Patients with Systemic Sclerosis

Who this might be right for
Systemic Sclerosis (SSc)Sexual DysfunctionsPelvic Floor Disorder
Istanbul University - Cerrahpasa 140
Testing effectiveness (Phase 2)Ended earlyNCT00226889
What this trial is testing

Treatment of Early Systemic Sclerosis by Bosentan

Who this might be right for
Systemic Sclerosis (Scleroderma)
Rikshospitalet University Hospital 30
Early research (Phase 1)Enrolling By InvitationNCT07038447
What this trial is testing

KITE-363 in Participants With Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisSystemic Sclerosis+1 more
Kite, A Gilead Company 52
Testing effectiveness (Phase 2)Ended earlyNCT04781543
What this trial is testing

Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic SclerosisSclerosis, Systemic
Amgen 301
Testing effectiveness (Phase 2)Looking for participantsNCT05149768
What this trial is testing

Open Label Extension Study of Brentuximab Vedotin in Early dcSSc

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 11
Large-scale testing (Phase 3)Study completedNCT06758947
What this trial is testing

Use of Selective JAK Inhibitor in ILD and Skin Tightness of Systemic Sclerosis Versus MMF

Who this might be right for
Interstitial Lung Disease Due to Systemic Disease (Disorder)
Assiut University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06947460
What this trial is testing

CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH

Who this might be right for
Refractory Lupus NephritisSystemic SclerosisPrimary Sjogren's Syndrome Combined With Pulmonary Hypertension
Beijing GoBroad Hospital 45
Not applicableUnknownNCT00617487
What this trial is testing

Pulmonary Arterial Hypertension in Systemic Sclerosis

Who this might be right for
Systemic SclerosisPulmonary Arterial Hypertension
Fondazione IRCCS Policlinico San Matteo di Pavia 200
Testing effectiveness (Phase 2)Study completedNCT02161406
What this trial is testing

Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Dinesh Khanna, MD, MS 88
Not applicableUnknownNCT06105073
What this trial is testing

"Pulmonary Rehabilitation Program in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis"

Who this might be right for
Systemic Sclerosis Associated Interstitial Lung Disease
Coordinación de Investigación en Salud, Mexico 67
Early research (Phase 1)Looking for participantsNCT07361094
What this trial is testing

Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Relapsed/Refractory Systemic Lupus ErythematosusRelapsed/Refractory Systemic SclerosisRelapsed/Refractory Idiopathic Inflammatory Myopathies+3 more
Beijing Boren Hospital 12
Not applicableStudy completedNCT02789670
What this trial is testing

Analysis of the Distribution of Regulatory B Cells in Blood of Multiple Sclerosis Patients

Who this might be right for
Multiple SclerosisSystemic Sclerosis
University Hospital, Lille 137
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07287670
What this trial is testing

EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Mediar Therapeutics 85
Load More Results